Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|August 8, 2006
The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trialsHallvard Holdaas, Christoph Wanner, Claudia Abletshauser, et al.
Renal Failure|August 25, 2006
The renal safety profile of fluvastatin: results of a pooled analysisHallvard Holdaas, Christoph Wanner, Claudia Abletshauser, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 1, 2006
Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortalityInga Soveri, Hallvard Holdaas, Alan Jardine, et al.
Clinical Therapeutics|November 24, 2007
Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trialsKarl Winkler, Claudia B Ablethauser, Claudio Gimpelewicz, et al.
Clinical Transplantation|November 15, 2006
No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) studyBengt Fellström, Sadollah Abedini, Hallvard Holdaas, et al.
Transplantation|May 10, 2005
Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: experience from the Assessment of Lescol in Renal Transplantation trialBengt Fellström, Alan G Jardine, Inga Soveri, et al.
European Journal of Heart Failure|June 22, 2013
Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT studyAnastasia Lesogor, Jay N Cohn, Roberto Latini, et al.
European Journal of Heart Failure|December 3, 2010
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT)Mihai Gheorghiade, Mazen Albaghdadi, Faiez Zannad, et al.
European Journal of Heart Failure|December 21, 2010
Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) studyHenry Krum, Barry Massie, William T Abraham, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 24, 2005
Beneficial effect of early initiation of lipid-lowering therapy following renal transplantationHallvard Holdaas, Bengt Fellström, Alan G Jardine, et al.
Pageof 4